Your Gut Isn't Broken. Your Genes Are Just Speaking a Language Nobody Listened To.

FUT2 is a fucosyltransferase, an enzyme that attaches sugars to the cells lining your gut. This seems technical, but what it actually does is create a specific chemical environment that your gut bacteria use as food. It shapes which species of bacteria can colonize your intestines. It also influences how well you absorb vitamin B12 from your food.

If you carry the non-secretor variant of FUT2, roughly 20% of people do, your gut creates a different chemical environment. This means certain beneficial bacteria species can’t thrive the way they do in secretors. Your microbiome composition is shifted. And your intestinal cells absorb B12 less efficiently. You can eat plenty of B12-rich foods and still become functionally B12-depleted at the cellular level because the absorption mechanism itself is impaired.

This shows up as a very specific weight loss pattern: you might lose weight initially on a standard protocol, but it stalls. Your energy tanks. You develop brain fog. You feel cold. These are signs your B12 is insufficient. Your appetite regulation actually depends on B12 status (B12 is essential for homocysteine metabolism, which affects appetite hormones). Microbiome dysbiosis (the wrong bacteria balance) also promotes inflammation and bloating.

The VDR gene produces the receptor protein that lets every cell in your body actually use vitamin D. Think of vitamin D as a hormone-like signal and VDR as the antenna that receives it. Without a functioning antenna, vitamin D levels in your blood can be high, but your cells can’t hear the signal. This is why some people feel better with vitamin D supplementation and others don’t, regardless of their blood levels.

Certain VDR variants reduce the efficiency of this receptor. Your cells become less responsive to vitamin D signaling, even when your 25-OH vitamin D levels look adequate on blood work. You need higher circulating vitamin D to achieve the same biological effect as someone with an optimized VDR. Vitamin D controls dozens of metabolic genes, including those involved in insulin secretion, appetite regulation, and immune function in the gut.

When VDR signaling is impaired, insulin sensitivity suffers. Your appetite regulation flattens. Your gut barrier becomes more permeable (vitamin D maintains tight junctions in the intestinal lining). You gain weight more easily, especially around the abdomen. Inflammation rises silently. Your microbiome diversity decreases because vitamin D is essential for healthy mucosal immunity.

MTHFR converts folate into methylfolate, the active form your cells actually use. This active form is essential for dozens of metabolic processes: making new DNA, recycling amino acids, producing energy, clearing homocysteine, regulating inflammation, and supporting neurotransmitter synthesis. Your entire metabolism depends on this one enzyme working smoothly.

The MTHFR C677T variant, carried by roughly 40% of people of European ancestry, reduces this enzyme’s efficiency by 40-70%. Your cells have to work harder to generate the methylfolate they need. This creates a bottleneck. Even if you eat plenty of folate-rich foods, your cells can’t convert it fast enough to meet demand. You can follow a perfect diet and still be functionally depleted at the cellular level because the conversion step itself is slow.

For weight loss specifically, this matters enormously. A sluggish methylation cycle impairs homocysteine clearance (elevated homocysteine interferes with leptin signaling and appetite regulation). It reduces your capacity to handle detoxification, so environmental toxins accumulate and trigger inflammation. Your energy production falters because methylation-dependent ATP synthesis slows down. Your metabolism downshifts. You feel tired on a calorie deficit. You regain weight quickly when you reintroduce normal eating because your metabolic flexibility is compromised.

FTO is the fat mass and obesity gene. It doesn’t determine your body weight directly, but it does control appetite signaling in your brain. Specifically, it affects how strongly you feel satiety (fullness) after eating and how much your brain’s reward system is triggered by high-fat, high-calorie foods.

The FTO rs9939609 A allele, present in roughly 45% of people of European ancestry, impairs satiety signaling. This doesn’t mean you’re weak-willed or lack discipline. Your brain’s appetite regulation circuit is literally less efficient at telling you to stop eating. You feel hunger more intensely. You feel fullness less completely. Fatty, calorie-dense foods trigger stronger reward responses in your brain. Portion control requires you to fight against your own neurobiology.

This shows up very specifically: you can eat a reasonable meal and feel hungry 30 minutes later. You crave fatty foods intensely. You eat past fullness without noticing. Standard calorie restriction frustrates you because you’re working against your genetic appetite set-point. You might succeed for a while through willpower, but the genetic signal never stops. You regain weight as soon as willpower fades because the appetite dysregulation is still there.

PPARG produces a protein that controls where your body decides to store fat and how efficiently it stores it. Think of PPARG as the master regulator of adipose (fat) tissue development and function. It determines whether your body prioritizes storing fat in visceral depots (around your organs, which is metabolically toxic) or subcutaneous depots (under the skin, which is less harmful). It also affects how sensitive your fat cells are to insulin.

The PPARG Pro12 allele, present in roughly 25% of people, promotes efficient fat storage. This sounds counterintuitive until you understand what it means metabolically: your fat cells are really good at taking up glucose and storing it as triglycerides. This means your body readily converts excess calories into fat storage and holds onto that fat stubbornly. The flip side: low-fat diets often backfire because your body is already efficient at storing carbohydrates as fat.

You see this in the weight loss pattern: a low-fat, high-carb diet that works beautifully for someone else leaves you feeling deprived and hungry while you gain weight. Your insulin rises too high in response to carbs. Your fat cells absorb that glucose aggressively. Your body prioritizes fat storage over fat mobilization. You’re fighting against your fat cell biology.

TCF7L2 is a transcription factor that controls the gene expression of GLP-1, a hormone that triggers insulin secretion in response to food. When you eat, your gut should release GLP-1, which tells your pancreas to release insulin at just the right time and amount to handle the incoming glucose. TCF7L2 orchestrates this whole timing system.

The TCF7L2 rs7903146 T allele, present in roughly 30% of people, impairs incretin-stimulated insulin secretion. This is the single strongest common genetic risk factor for type 2 diabetes. What it means practically: your pancreas doesn’t secrete insulin as efficiently in response to food, so your blood sugar rises higher and stays elevated longer. Your insulin response is delayed or blunted. Your cells don’t respond as well to the insulin that is released (insulin resistance develops).

This creates a very specific weight loss problem: you can eat a moderate amount of carbohydrates and experience blood sugar spikes that would be normal for someone else. Those spikes trigger fat storage and eventually lead to reactive hunger as blood sugar crashes. Fasting doesn’t help you because your liver gluconeogenesis is inefficient. You feel trapped: you can’t eat much carbohydrate without spiking blood sugar, but you can’t fast effectively either because your body isn’t generating stable glucose internally.